雷鸣

雷鸣, listed as board member, appears in our data through filings on 鹭燕医药 shares, published by SSE / SZSE (CSRC). The record holds 4 filings, for trades running from 15 December 2021 to 28 November 2024.

On the market, this insider has only sold: 4 sales, €290k in total. So far in 2024, the count stands at no purchases and 1 sale.

The record was last updated on 28 November 2024 with an open-market sale (€67k) in 鹭燕医药. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.